Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-141628)

Filing Details

Accession Number:: 0001104659-21-141628
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-19 08:13:32
Reporting Period:: 2021-11-17

Accepted Time:: 2021-11-19 08:13:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750149	Inhibikase Therapeutics Inc.	IKT	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1827621	H. Milton Werner	3350 Riverwood Parkway Se, Suite 1900 Atlanta GA 30339	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-17	17,569	$1.98	23,589	No	4	P	Indirect	Domestic Partner
Common Stock	Acquisiton	2021-11-17	1,100	$1.97	23,589	No	4	P	Indirect	Domestic Partner
Common Stock	Acquisiton	2021-11-17	3,186	$1.96	23,589	No	4	P	Indirect	Domestic Partner
Common Stock	Acquisiton	2021-11-17	1,334	$1.94	23,589	No	4	P	Indirect	Domestic Partner
Common Stock	Acquisiton	2021-11-17	400	$1.93	23,589	No	4	P	Indirect	Domestic Partner

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Domestic Partner
No	4	P	Indirect	Domestic Partner
No	4	P	Indirect	Domestic Partner
No	4	P	Indirect	Domestic Partner
No	4	P	Indirect	Domestic Partner

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,293,580	Direct

Footnotes

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.